Stereotactic body radiation therapy versus sublobar resection for stage I NSCLC
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference32 articles.
1. N.C.C.C. Guidelines, Non-Small Cell Lung Cancer,2018
2. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer study Group;Ginsberg;Ann. Thorac. Surg.,1995
3. Non-small cell lung Cancer, version 5.2017, NCCN clinical practice guidelines in oncology;Ettinger;J. Natl. Compr. Cancer Netw.: JNCCN,2017
4. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy;Baumann;J. Clin. Oncol.,2009
5. Prospective trial of stereotactic body radiation therapy for both operable and inoperable T1N0M0 non-small cell lung Cancer: Japan clinical oncology group study JCOG0403;Nagata;Int. J. Radiat. Oncol. Biol. Phys.,2015
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Wedge Resection versus Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer Tumors ≤8 mm;Current Oncology;2024-03-15
2. Commentary: Nothing is free: Surgeons' and radiation oncologists’ biases about treating early-stage lung cancer in healthy patients;The Journal of Thoracic and Cardiovascular Surgery;2023-10
3. Development of a multi-feature-combined model: proof-of-concept with application to local failure prediction of post-SBRT or surgery early-stage NSCLC patients;Frontiers in Oncology;2023-09-13
4. Optimal Radiation Therapy Fractionation Regimens for Early-Stage Non-Small Cell Lung Cancer;International Journal of Radiation Oncology*Biology*Physics;2023-09
5. Place de la radiothérapie stéréotaxique pour les cancers bronchiques non à petites cellules de stade I opérables;Cancer/Radiothérapie;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3